î
îž
āļĨāđāļāļāļāļīāļ
î
GE Healthcare Technologies Inc
GEHC71.540USD
-0.660-0.91%
āļāļīāļÂ 03/26, 16:00ïžETïžāļĢāļēāļāļēāļĨāđāļēāļāđāļē 15 āļāļēāļāļĩ
32.53BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
15.65P/E TTM
î
āļĢāļēāļĒāļĨāļ°āđāļāļĩāļĒāļāđāļāļīāđāļĄāđāļāļīāļĄāļāļāļ GE Healthcare Technologies Inc āļāļĢāļīāļĐāļąāļ
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
āļāđāļāļĄāļđāļĨ GE Healthcare Technologies Inc
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļGEHC
āļāļ·āđāļāļāļĢāļīāļĐāļąāļGE Healthcare Technologies Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 15, 2022
āļāļĩāļāļĩāđāļBankes (Jeannette)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ53000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 15
āļāļĩāđāļāļĒāļđāđ500 West Monroe Street
āđāļĄāļ·āļāļCHICAGO
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ60661
āđāļāļĢāļĻāļąāļāļāđ18337351139
āđāļ§āđāļāđāļāļāđhttps://www.gehealthcare.com
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļGEHC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 15, 2022
āļāļĩāļāļĩāđāļBankes (Jeannette)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ GE Healthcare Technologies Inc
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
510.32K
+39.24%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
76.89K
+11.15%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.18%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
--
Mr. Frank R. Jimenez
Mr. Frank R. Jimenez
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
--
--
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
510.32K
+39.24%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
76.89K
+11.15%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.18%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
--
āļŠāļąāļāļŠāđāļ§āļāļāļāļāļĢāļēāļĒāđāļāđ
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 6 āļĄ.āļ.
āļŠāļāļļāļĨāđāļāļīāļ: USDāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļēāļĢāļāļĩāđ 6 āļĄ.āļ.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Total Imaging
2.35B
45.67%
Total Ultrasound
1.30B
25.30%
Total PDx
749.00M
14.56%
Total PCS
731.00M
14.21%
Other
15.00M
0.29%
āļāđāļāļĄāļđāļĨāļāļĩāđāđāļāļĩāđāļĒāļ§āļāđāļāļāļĒāļąāļāđāļĄāđāđāļāđāļĢāļąāļāļāļēāļĢāđāļāļīāļāđāļāļĒāļāļēāļāļāļēāļāļāļĢāļīāļĐāļąāļ
āļāļēāļĄāļāļļāļĢāļāļīāļ
āļāļēāļĄāļ āļđāļĄāļīāļ āļēāļ
āļāļēāļĄāļāļļāļĢāļāļīāļUSD
āļāļ·āđāļ
āļĢāļēāļĒāđāļāđ
āļŠāļąāļāļŠāđāļ§āļ
Total Imaging
2.35B
45.67%
Total Ultrasound
1.30B
25.30%
Total PDx
749.00M
14.56%
Total PCS
731.00M
14.21%
Other
15.00M
0.29%
āļŠāļāļīāļāļīāļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļĻāļļāļāļĢāđāļāļĩāđ 20 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļĻāļļāļāļĢāđāļāļĩāđ 20 āļ.āļ.
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
The Vanguard Group, Inc.
11.41%
Dodge & Cox
6.84%
Capital Research Global Investors
5.56%
BlackRock Institutional Trust Company, N.A.
5.47%
State Street Investment Management (US)
4.39%
āļāļ·āđāļ āđ
66.33%
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
The Vanguard Group, Inc.
11.41%
Dodge & Cox
6.84%
Capital Research Global Investors
5.56%
BlackRock Institutional Trust Company, N.A.
5.47%
State Street Investment Management (US)
4.39%
āļāļ·āđāļ āđ
66.33%
āļāļĢāļ°āđāļ āļāļāļđāđāļāļ·āļāļŦāļļāđāļ
āļāļđāđāļāļ·āļāļŦāļļāđāļ
āļŠāļąāļāļŠāđāļ§āļ
Investment Advisor
50.15%
Investment Advisor/Hedge Fund
30.28%
Pension Fund
2.94%
Hedge Fund
2.92%
Research Firm
2.88%
Sovereign Wealth Fund
1.96%
Bank and Trust
1.21%
Insurance Company
0.97%
Individual Investor
0.30%
āļāļ·āđāļ āđ
6.40%
āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 8 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāļāļąāļāļāļĢāđāļāļĩāđ 8 āļ.āļ.
āļāđāļ§āļāđāļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļāļēāļ
āļāļģāļāļ§āļāļŠāļāļēāļāļąāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
2025Q4
2310
400.60M
85.71%
--
2025Q3
2366
400.81M
86.07%
+553.52K
2025Q2
2431
400.55M
88.05%
+24.13M
2025Q1
2426
405.65M
95.66%
-32.34M
2024Q4
2331
419.80M
91.27%
+20.88M
2024Q3
2167
398.38M
86.23%
+22.39M
2024Q2
2063
375.84M
84.85%
+4.36M
2024Q1
1976
370.75M
77.53%
+16.94M
2023Q4
1833
338.14M
75.18%
+5.23M
2023Q3
1683
332.60M
72.95%
+3.23M
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļīāļāļāļĢāļĢāļĄāļāļđāđāļāļ·āļāļŦāļļāđāļ
îāļāļ·āđāļ
āļŦāļļāđāļāļāļĩāđāļāļ·āļāļāļĢāļāļ
āļŠāļąāļāļŠāđāļ§āļ
āđāļāļĨāļĩāđāļĒāļ
āđāļāļĨāļĩāđāļĒāļ%
āļ§āļąāļāļāļĩāđ
The Vanguard Group, Inc.
51.80M
11.37%
-103.46K
-0.20%
Sep 30, 2025
Dodge & Cox
27.52M
6.04%
+3.95M
+16.76%
Sep 30, 2025
Capital Research Global Investors
24.97M
5.48%
+5.00M
+25.02%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
24.66M
5.41%
+32.68K
+0.13%
Sep 30, 2025
State Street Investment Management (US)
19.65M
4.31%
-13.00K
-0.07%
Sep 30, 2025
Harris Associates L.P.
11.02M
2.42%
+1.35M
+13.95%
Sep 30, 2025
Geode Capital Management, L.L.C.
12.08M
2.65%
+130.94K
+1.10%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
10.22M
2.24%
+649.11K
+6.78%
Dec 31, 2025
Hotchkis and Wiley Capital Management, LLC
8.43M
1.85%
+1.23M
+17.12%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
6.32M
1.39%
+71.17K
+1.14%
Jun 30, 2025
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ETF āļāļĩāđāđāļāļĩāđāļĒāļ§āļāđāļāļ
îāļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļąāļāđāļāļāđāļĄāļ·āđāļ: āļ§āļąāļāđāļŠāļēāļĢāđāļāļĩāđ 6 āļ.āļ.
āļāļ·āđāļ
āļŠāļąāļāļŠāđāļ§āļ
Invesco S&P Spin-Off ETF
7.25%
Global X HealthTech ETF
4.14%
iShares U.S. Medical Devices ETF
4.07%
Absolute Select Value ETF
2.89%
VanEck Morningstar Wide Moat ETF
2.36%
Knowledge Leaders Developed World ETF
2.22%
Invesco Zacks Mid-Cap ETF
1.91%
Simplify Health Care ETF
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.75%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Invesco S&P Spin-Off ETF
āļŠāļąāļāļŠāđāļ§āļ7.25%
Global X HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ4.14%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ4.07%
Absolute Select Value ETF
āļŠāļąāļāļŠāđāļ§āļ2.89%
VanEck Morningstar Wide Moat ETF
āļŠāļąāļāļŠāđāļ§āļ2.36%
Knowledge Leaders Developed World ETF
āļŠāļąāļāļŠāđāļ§āļ2.22%
Invesco Zacks Mid-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ1.91%
Simplify Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.77%
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
āļŠāļąāļāļŠāđāļ§āļ1.75%
āđāļāļīāļāļāļąāļāļāļĨ
îāļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
96.00M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
āļ§āļąāļāļāļĩāđ
āđāļāļīāļāļāļąāļāļāļĨ
āļ§āļąāļāļāļĩāđāļāļąāļāļāļķāļ
āļ§āļąāļāļāļĩāđāļāļģāļĢāļ°āđāļāļīāļ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
Feb 12, 2026
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2026 going ex on Apr 02, 2026
Apr 03, 2026
May 15, 2026
Apr 02, 2026
Nov 24, 2025
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 13, 2026 going ex on Jan 09, 2026
Jan 09, 2026
Feb 13, 2026
Jan 09, 2026
Sep 24, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Nov 14, 2025 going ex on Oct 24, 2025
Oct 24, 2025
Nov 14, 2025
Oct 24, 2025
Jul 01, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Aug 15, 2025 going ex on Jul 25, 2025
Jul 25, 2025
Aug 15, 2025
Jul 25, 2025
Mar 27, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2025 going ex on Apr 25, 2025
Apr 25, 2025
May 15, 2025
Apr 25, 2025
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļēāļĢāđāļāđāļāļŦāļļāđāļ
îāļ§āļąāļāļāļĩāđ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
āļ§āļąāļāļāļĩāđ
āļ§āļąāļāļāļĩāđāđāļĄāđāđāļāđāļĢāļąāļāļŠāļīāļāļāļīāļāļąāļāļāļĨ
āļāļĢāļ°āđāļ āļ
āļāļąāļāļĢāļēāļŠāđāļ§āļ
āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ
